Articles

Medications

Side profile silhouette with illuminated brain showing neural connections branching into tree-like growth, with molecular structures, symbolizing psychoplastogens and brain plasticity without psychedelic effects
Mental Health
9
min read

The Psychoplastogen Question: Plasticity Without Psychedelia

A new class of compounds aims to harness brain plasticity without hallucinogenic effects. Justin Ray, MSN, PMHNP-BC of South Chesapeake Psychiatry examines psychoplastogens and what they could mean for the future of depression treatment for patients in Chesapeake, VA and across Hampton Roads.

Read More
Psychiatric clinician and patient in conversation with overlay icons representing sleep changes, nausea, dizziness, mood, focus, energy, and shared decisions, centered on a benefits versus risks scale
Mental Health
14
min read

Side Effects and the Conversation Behind Psychiatric Medication Management

Side effects are not a footnote to psychiatric treatment - they are often the center of it. In this edition of The Neuropsychiatry Brief, Justin Ray, MSN, PMHNP-BC of South Chesapeake Psychiatry explains why treatment-emergent adverse events drive real-world decisions, and what that means for medication management in Chesapeake, VA.

Read More
Cannabis leaf and prescription medication bottle illustrating drug interaction risks
Mental Health
4
min read

Cannabis Use and Potential Interference with Antidepressant Medications

Cannabis use has become increasingly common among people who also take prescription antidepressants. This overlap is clinically important because cannabinoids, especially cannabidiol (CBD), may alter the metabolism of certain antidepressant medications and increase the likelihood of adverse effects.

Read More
The Neuropsychiatry Brief LinkedIn newsletter cover graphic
Mental Health
min read

The Neuropsychiatry Brief Newsletter

Subscribe to Justin Ray's newsletter on Linkedin : The Neuropsychiatry Brief

Read More
Clinician reviewing Cobenfy treatment options for schizophrenia care
Mental Health
2
min read

What Psychiatric Times Got Right About Cobenfy — and Why Switching Matters

When I read the recent Psychiatric Times reflection on the first year of Cobenfy in real-world practice, I found myself agreeing with much of what was said because the article finally acknowledged what many of us have learned the hard way: the medication itself has not been the limiting factor. Implementation has (Weiden, 2026).

Read More
Abstract metabolic and brain network illustration representing GLP-1 receptor research
Mental Health
3
min read

WVE-007 and the Expanding Role of Metabolic Treatments in Mental Health Care

The landscape of metabolic medicine has changed significantly over the past several years, largely driven by the impact of GLP-1 receptor agonists.

Read More

Take the first step towards medication and care that can help you feel better.

Schedule an appointment today to get diagnosed, receive a prescription, and continue your journey towards mental peace.

Schedule An Appointment
The lobby of South Chesapeake Psychiatry with seating and a front desk.